<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Analyst inititations: FREE, NKTR, ALTU and ABH]]></title><link>http://www.bloggingstocks.com/2007/11/09/analyst-inititations-free-nktr-altu-and-abh/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/11/09/analyst-inititations-free-nktr-altu-and-abh/</guid><comments>http://www.bloggingstocks.com/2007/11/09/analyst-inititations-free-nktr-altu-and-abh/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/analyst-reports/" rel="tag">Analyst Reports</a>, <a href="http://www.bloggingstocks.com/category/ua/" rel="tag">Under Armour'A' (UA)</a>, <a href="http://www.bloggingstocks.com/category/analyst-initiations/" rel="tag">Analyst Initiations</a>, <a href="http://www.bloggingstocks.com/category/ptr/" rel="tag">PetroChina Co Ltd ADR (PTR)</a></p><strong><a href="http://www.theflyonthewall.com/splashPage.php?source=AOL"><img vspace="4" hspace="4" border="1" align="right" alt="" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/11/fly-logo-(aol).gif" /></a>MOST NOTEWORTHY:</strong> FreeSeas, Nektar, Altus Pharmaceuticals and AbitibiBowater were today's noteworthy initiations:<br />
<ul>
    <li>Cantor initiated shares of <a href="http://finance.aol.com/quotes/freeseas-inc/free/nas">FreeSeas</a> (NASDAQ: <a href="http://finance.aol.com/quotes/freeseas-inc/free/nas">FREE</a>) with a Buy rating and $10 target, as they expect the company to benefit from the continued strength in the dry bulk market. <br /></li>
    <li>JP Morgan resumed coverage of <a href="http://finance.aol.com/quotes/nektar-therapeutics/nktr/nas">Nektar</a> (NASDAQ: <a href="http://finance.aol.com/quotes/nektar-therapeutics/nktr/nas">NKTR</a>) with an Overweight rating, as they view weakness from the discontinuation of Exubera as a buying opportunity given the company's base royalty business and pipeline opportunities. <br /></li>
    <li><a href="http://finance.aol.com/quotes/altus-pharmaceuticals-inc/altu/nas">Altus Pharmaceuticals</a> (NASDAQ: <a href="http://finance.aol.com/quotes/altus-pharmaceuticals-inc/altu/nas">ALTU</a>) was initiated with a Buy rating and $19 target at Jefferies. The firm expects news flow from the company's two lead products over the next 6-12 months that should act as catalysts. <br /></li>
    <li><a href="http://finance.aol.com/quotes/abitibibowater-inc/abh/nys">AbitibiBowater</a> (NYSE: <a href="http://finance.aol.com/quotes/abitibibowater-inc/abh/nys">ABH</a>) was initiated with a Sell rating and $18 target at Banc of America, as they are cautious on newsprint trends; the firm recommends reducing existing positions.</li>
</ul>
<strong>OTHER INITIATIONS:</strong><br />
<ul>
    <li>Caris initiated <a href="http://finance.aol.com/quotes/collective-brands-inc/pss/nys">Collective Brands</a> (NYSE: <a href="http://finance.aol.com/quotes/collective-brands-inc/pss/nys">PSS</a>) with an Average rating and $18 target and <a href="http://finance.aol.com/quotes/under-armour-inc/ua/nys">Under Armour</a> (NYSE: <a href="http://finance.aol.com/quotes/under-armour-inc/ua/nys">UA</a>) with an Above Average rating. <br /></li>
    <li>Stifel started shares of <a href="http://finance.aol.com/quotes/patriot-coal-corp/pcx/nys">Patriot Coal</a> (NYSE: <a href="http://finance.aol.com/quotes/patriot-coal-corp/pcx/nys">PCX</a>) with a Hold rating. <br /></li>
    <li><a href="http://finance.aol.com/quotes/petrochina-company-limited/ptr/nys">PetroChina</a> (NYSE: <a href="http://finance.aol.com/quotes/petrochina-company-limited/ptr/nys">PTR</a>) was initiated with a Sell rating at Goldman.</li>
</ul><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/11/09/analyst-inititations-free-nktr-altu-and-abh/">Analyst inititations: FREE, NKTR, ALTU and ABH</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 09 Nov 2007 11:20:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/11/09/analyst-inititations-free-nktr-altu-and-abh/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1035199/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/11/09/analyst-inititations-free-nktr-altu-and-abh/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>abh</category><category>abitibibowater</category><category>altu</category><category>altus</category><category>analyst</category><category>collective brands</category><category>CollectiveBrands</category><category>free</category><category>freeseas</category><category>initiation</category><category>nektar</category><category>nktr</category><category>patriot coal</category><category>PatriotCoal</category><category>pcx</category><category>petrochina</category><category>pss</category><category>ptr</category><category>ua</category><category>under armour</category><category>UnderArmour</category><dc:creator><![CDATA[Eric Buscemi]]></dc:creator><pubDate>Fri, 09 Nov 2007 11:20:00 EST</pubDate></item><item><title><![CDATA[Analyst upgrades 5-10-07: B, MA, NVDA and PZZA]]></title><link>http://www.bloggingstocks.com/2007/05/10/analyst-upgrades-5-10-07-brl-nvda-ma-and-pzza/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/05/10/analyst-upgrades-5-10-07-brl-nvda-ma-and-pzza/</guid><comments>http://www.bloggingstocks.com/2007/05/10/analyst-upgrades-5-10-07-brl-nvda-ma-and-pzza/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/before-the-bell/" rel="tag">Before the Bell</a>, <a href="http://www.bloggingstocks.com/category/analyst-upgrades-and-downgrades/" rel="tag">Analyst Upgrades and Downgrades</a>, <a href="http://www.bloggingstocks.com/category/good-news/" rel="tag">Good news</a>, <a href="http://www.bloggingstocks.com/category/ma/" rel="tag">MasterCard Inc'A' (MA)</a></p><strong><a href="http://www.theflyonthewall.com/splashPage.php?source=AOL"><img vspace="4" hspace="4" border="1" align="right" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/05/aol-fly-logo.gif"  alt="" /></a>MOST NOTEWORTHY:</strong> Today's noteworthy upgrades include Papa John's Int'l, Inc (PZZA), ExpressJet Holdings, Inc (XJT), Nvidia Corp (NVDA),Georgia Gulf Corp (GGC) and MasterCard (MA): <br />
<ul>
    <li>Following Q1 results, Oppenheimer upgraded shares of <a href="http://finance.aol.com/quotes/papa-john-s-international-inc/pzza/nas">Papa John's Int'l, Inc </a>(NASDAQ: <a href="http://finance.aol.com/quotes/papa-john-s-international-inc/pzza/nas">PZZA</a>) to Buy from Neutral, citing better-than-expected revenue growth, improved margins and acquisitions. </li>
</ul>
<ul>
    <li>Soleil upgraded shares of <a href="http://finance.aol.com/quotes/expressjet-holdings-inc/xjt/nys?tabs=quotesandnews">ExpressJet Holdings</a> (NYSE: <a href="http://finance.aol.com/quotes/expressjet-holdings-inc/xjt/nys?tabs=quotesandnews">XJT</a>) to Hold from Sell with a $7 target due to the likely absence of any real news until at least August. </li>
</ul>
<ul>
    <li>Deutsche Bank assumed shares of <a href="http://finance.aol.com/quotes/nvidia-corporation/nvda/nas?tabs=quotesandnews">Nvidia </a>(NASDAQ: <a href="http://finance.aol.com/quotes/nvidia-corporation/nvda/nas?tabs=quotesandnews">NVDA</a>) with a Buy, up from Hold, as the firm believes Vista will accelerate NVDA's growth rates making their 2008 estimates conservative. </li>
</ul>
<ul>
    <li>Citigroup upgraded shares of <a href="http://finance.aol.com/quotes/georgia-gulf-corporation/ggc/nys?tabs=quotesandnews">Georgia Gulf Corp </a>(NYSE: <a href="http://finance.aol.com/quotes/georgia-gulf-corporation/ggc/nys?tabs=quotesandnews">GGC</a>) to Buy from Sell based on an improved near-term outlook. </li>
</ul>
<ul>
    <li><a href="http://finance.aol.com/quotes/mastercard-incorporated/ma/nys?tabs=quotesandnews">MasterCard</a> (NYSE: <a href="http://finance.aol.com/quotes/mastercard-incorporated/ma/nys?tabs=quotesandnews">MA</a>)  was upgraded to Hold from Sell at Stifel based on the lenders impressive Q1 results and pricing power... </li>
</ul>
<strong>OTHER UPGRADES: </strong><br />
<ul>
    <li>Baird upgraded <a href="http://finance.aol.com/quotes/barnes-group-inc/b/nys?tabs=quotesandnews">Barnes Group Inc</a> (NYSE:<a href="http://finance.aol.com/quotes/barnes-group-inc/b/nys?tabs=quotesandnews"> B</a>) to Outperform from Neutral. </li>
</ul>
<ul>
    <li><a href="http://finance.aol.com/quotes/pacific-ethanol-inc-commonstock/peix/nas?tabs=quotesandnews">Pacific Ethanol Inc </a>(NASDAQ: <a href="http://finance.aol.com/quotes/pacific-ethanol-inc-commonstock/peix/nas?tabs=quotesandnews">PEIX</a>) was raised to Hold from Sell at Hambrecht. </li>
</ul>
<ul>
    <li><a href="http://finance.aol.com/quotes/lca-vision-inc/lcav/nas?tabs=quotesandnews">LCA-Vision Inc</a> (NASDAQ: <a href="http://finance.aol.com/quotes/lca-vision-inc/lcav/nas?tabs=quotesandnews">LCAV</a>) was upgraded to Buy from Neutral at Oppenheimer. </li>
</ul>
<ul>
    <li>Bernstein raised <a href="http://finance.aol.com/quotes/barr-pharmaceuticals-inc/brl/nys?tabs=quotesandnews">Barr Pharmaceuticals, Inc</a> (NYSE: <a href="http://finance.aol.com/quotes/barr-pharmaceuticals-inc/brl/nys?tabs=quotesandnews">BRL</a>) to Outperform from Market Perform. </li>
</ul>
<ul>
    <li>Morgan Stanley upgraded <a href="http://finance.aol.com/quotes/nektar-therapeutics/nktr/nas?tabs=quotesandnews">Nektar Therapeutics</a> (NASDAQ: <a href="http://finance.aol.com/quotes/nektar-therapeutics/nktr/nas?tabs=quotesandnews">NKTR</a>) to Equal Weight from Underweight.</li>
</ul>
<em>Analyst summaries provided by <a href="http://www.theflyonthewall.com/splashPage.php?source=AOL">TheFlyOnTheWall.com</a> (subscription required).</em><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/05/10/analyst-upgrades-5-10-07-brl-nvda-ma-and-pzza/">Analyst upgrades 5-10-07: B, MA, NVDA and PZZA</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Thu, 10 May 2007 11:02:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/05/10/analyst-upgrades-5-10-07-brl-nvda-ma-and-pzza/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/893084/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/05/10/analyst-upgrades-5-10-07-brl-nvda-ma-and-pzza/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>analyst</category><category>barnes</category><category>barr</category><category>brl</category><category>expressjet</category><category>georgia</category><category>ggc</category><category>lca</category><category>lcav</category><category>ma</category><category>mastercard</category><category>nektar</category><category>nktr</category><category>nvda</category><category>nvidia</category><category>pacific ethanol</category><category>PacificEthanol</category><category>papa johns</category><category>PapaJohns</category><category>peix</category><category>pzza</category><category>rating</category><category>theflyonthewall.com</category><category>xjt</category><dc:creator><![CDATA[Kevin Shult]]></dc:creator><pubDate>Thu, 10 May 2007 11:02:00 EST</pubDate></item><item><title><![CDATA[Pfizer's hand forced]]></title><link>http://www.bloggingstocks.com/2006/12/05/pfizers-hand-forced/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2006/12/05/pfizers-hand-forced/</guid><comments>http://www.bloggingstocks.com/2006/12/05/pfizers-hand-forced/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/forecasts/" rel="tag">Forecasts</a>, <a href="http://www.bloggingstocks.com/category/competitive-strategy/" rel="tag">Competitive Strategy</a>, <a href="http://www.bloggingstocks.com/category/pfe/" rel="tag">Pfizer (PFE)</a></p><a href="http://www.theflyonthewall.com"><img vspace="4" hspace="4" border="1" align="right" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2006/12/flywall_final_logo_mini.gif" id="vimage_1" alt="" /></a>The death of cholesterol drug Torcetrapib, which caused Pfizer's (NYSE:PFE) stock to plunge 12% yesterday, has forced the company into purchasing growth rather than developing it. With the company's biggest drug, Lipitor, losing patent exclusivity in 2010, Pfizer must now hurry to acquire potential blockbuster drugs to maintain revenue, since its own pipeline is all but dried up. Company VP David Shedlarz said of the M&amp;A market, "Now we will attack it with a greater sense of urgency."<br /><br />This desperation means overpaying for possible franchise drugs, which means a potential early Christmas for takeover targets. One such target, according to <a href="http://www.thedeal.com/servlet/ContentServer?cid=1164921106764&amp;pagename=TheDeal%2FTDDArticle%2FTDStandardArticle&amp;c=TDDArticle">TheDeal.com</a> [subscription required], is Sepracor (NASDAQ:SEPR), which makes sleep and allergy drugs. <span style="font-family: arial;">Another possible target, according to W.R. Hambrecht, is Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical company which makes drug delivery technologies.</span><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2006/12/05/pfizers-hand-forced/">Pfizer's hand forced</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Tue, 05 Dec 2006 11:15:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2006/12/05/pfizers-hand-forced/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/713038/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2006/12/05/pfizers-hand-forced/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>nektar</category><category>pfizer</category><category>sepracor</category><category>Thedeal.com</category><category>torcetrapib</category><dc:creator><![CDATA[Eric Buscemi]]></dc:creator><pubDate>Tue, 05 Dec 2006 11:15:00 EST</pubDate></item></channel></rss>
